Global Intelligence Database
A comprehensive review details how palladium-catalysis is accelerating the creation of epigenetic cancer drugs. This chemical precision offers a promising blueprint for designing next-generation therapeutics that target the very machinery of gene expression.
By Sharma, Rana, Thakur, Ojha, Mousavi, Dhingra, Nepali
Researchers have dramatically improved the performance of perovskite light-emitting diodes (PeLEDs) by reducing energetic disorder within the device's transport layers. By inserting a self-assembled monolayer to align molecules, the team achieved a remarkable 30.4% external quantum efficiency and extended the device's operational lifetime nine-fold.
By Luo, Zheng, Hua, Wang, Li, Zhou, Song, Miao, Jiang, Zhou, Qian, Zhang, Yin, Wang, Zhang, Zhang
Scientists have successfully tested Nanopore long-read sequencing as a replacement for older, DNA-heavy methods in diagnosing Myotonic Dystrophy Type 1. By using CRISPR/Cas9 to target specific genes, the method accurately measures genetic mutations, though challenges remain for embryo screening.
By Shichiri, Inagaki, Mariya, Murase, Sugimoto, Sugihara, Nishizawa, Kurahashi
This study uncovers a novel mechanism where cancer-associated genetic variants influence the N6-methyladenosine (m6A) RNA methylation landscape, leading to altered gene expression and RNA splicing in colorectal cancer. These findings underscore the epitranscriptome as a potential axis of oncogenic control, modulated by genetic variants.
By Han, Jang, Kim, Tan, Wilkinson, Jeong, Choe